Tech Company Financing Transactions
Theravent Funding Round
Private investors joined a $40 million Series D funding round for Theravent. This venture round was recorded on 7/13/2010.
Transaction Overview
Company Name
Announced On
7/13/2010
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Proceeds Purpose
Proceeds from the financing will be used to expand the commercialization efforts for the company's lead product, PROVENT Sleep Apnea Therapy, a daily use, prescription device indicated for the treatment of obstructive sleep apnea.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
373 South Willow St. 306
Mancheste, NH 03103
USA
Mancheste, NH 03103
USA
Phone
Website
Email Address
Overview
Theravent is a private medical device company that is dedicated to changing the lives of people with sleep-disordered breathing. Theravent has developed a new breakthrough therapy for obstructive sleep apnea (OSA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Wyles
Chief Medical Officer
Philip Westbrook
VP - R & D
Mike Favet
Browse more venture capital transactions:
Prev: 7/13/2010: Femta Pharmaceuticals venture capital transaction
Next: 7/13/2010: XDx venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs